tranylcypromine has been researched along with chiniofon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, ZA; Gal, S; Youdim, MB | 1 |
| Fisher, CA; Gibbons, RJ; Higgs, DR; Mettananda, S; Oppermann, U; Sloane-Stanley, JA; Taylor, S | 1 |
2 other study(ies) available for tranylcypromine and chiniofon
| Article | Year |
|---|---|
limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Blood Pressure; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Hippocampus; Hydroxyquinolines; Intestine, Small; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Tranylcypromine; Tyramine | 2010 |
Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
Topics: alpha-Globins; Antigens, CD34; beta-Thalassemia; Butyric Acid; Cell Culture Techniques; Enzyme Inhibitors; Erythroid Cells; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Hydroxyquinolines; Hydroxyurea; Molecular Sequence Annotation; Piperazines; RNA, Small Interfering; Small Molecule Libraries; Tranylcypromine; Vorinostat | 2017 |